Charles River Laboratories (CRL) Tops Q4 EPS by 5c, Provides Guidance
Tweet Send to a Friend
Charles River Laboratories (NYSE: CRL) reported Q4 EPS of $0.73, $0.05 better than the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
